Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Terlipressin
The First People's Hospital of Lianyungang
Terlipressin
1 trial -
Terlipressin treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Shock
1 trial -
Test Formula
United Therapeutics Europe Ltd
Cow's Milk Allergy
1 trial -
Tests of the expression of CXCL3 in various tissues
The First People's Hospital of Lianyungang
Diabetic Kidney Disease (DKD)
1 trial -
Thoracic Paravertebral Block with Local Anesthetic
The First People's Hospital of Lianyungang
Pulmonary Nodules
1 trial -
Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses
Sinovac Research and Development Co.,
Poliomyelitis
1 trial -
Tirzepatide
United Therapeutics Europe Ltd
Hypertension
1 trial -
Tolcapone
United Therapeutics Europe Ltd
Impulsive Behavior
1 trial -
Topical compound tripterygium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Active Rheumatoid Arthritis
1 trial -
Topical diclofenac sodium gel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hand Osteoarthritis
1 trial -
Tranexamic Acid 100Mg/Ml Inj Vil 10Ml
Hospital Authority, Hong Kong
Rotator Cuff Tears
1 trial -
Treatment
United Therapeutics Europe Ltd
Glucose Metabolism Disorders
1 trial -
Triferdine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Pregnancy Related
1 trial -
Tumour Biopsy and Venous Blood Tests
United Therapeutics Europe Ltd
Soft Tissue Sarcoma
1 trial -
UMULINE NPH
Takeda
Type 2 Diabetes
1 trial -
Ulinastatin
The First People's Hospital of Lianyungang
Acute Respiratory Distress Syndrome
1 trial -
Ultra low dose chest computed tomography (ULDCT)
Hospital Authority, Hong Kong
Tuberculosis, Pulmonary
1 trial -
Ultrasound Elastography
Jazz Pharmaceuticals Ireland Limited
Bone Marrow Transplant Complications
1 trial -
Umooze
Biotech Pharmaceutical Co.,
Benign Prostatic Hyperplasia
1 trial -
Unfractionated heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary PCI
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Obesity &Amp;Amp;Amp; Overweight
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Environmental Exposure
1 trial -
Urinary kallidinogenase for injection
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Urine Culture
United Therapeutics Europe Ltd
Urinary Tract Infection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources